Literature DB >> 26113195

Accuracy of Fetal Echocardiography in the Differential Diagnosis between Truncus Arteriosus and Pulmonary Atresia with Ventricular Septal Defect.

Olga Gómez1, Iris Soveral, Mar Bennasar, Fatima Crispi, Narcis Masoller, Edda Marimon, Joaquim Bartrons, Eduard Gratacós, Josep M Martinez.   

Abstract

OBJECTIVES: To report on the accuracy of fetal echocardiography in the distinction between truncus arteriosus communis (CAT) and pulmonary atresia with ventricular septal defect (PA-VSD) and to describe the association with extracardiac and chromosomal anomalies.
METHODS: This was a retrospective study on 31 fetuses with a single arterial trunk overriding a VSD with a nonidentifiable right ventricle outflow tract with anterograde flow. Data on the type of cardiac defect, gestational age, characteristics of the arterial trunk valve, presence of additional vascular, chromosomal and extracardiac abnormalities and postnatal outcome were obtained. Misdiagnosed cases were reevaluated by four-dimensional spatiotemporal image correlation (4D-STIC) echocardiography.
RESULTS: The overall diagnostic accuracy was 81% and increased to 93.5% with 4D-STIC. Chromosomal and extracardiac anomalies were detected in 40 and 27%, respectively. In the PA-VSD group, patent ductus arteriosus and major aortopulmonary collateral arteries (MAPCAs) were present in 70 and 50% of the cases, respectively, coexisting in 1 of 5 cases. MAPCAs were significantly associated with a right aortic arch and with a 22q11 microdeletion in 50% of cases.
CONCLUSIONS: A prenatal distinction between CAT and PA-VSD can currently be achieved in most cases. MAPCAs should be actively searched for when PA-VSD is suspected, as they are associated with a higher risk of 22q11 microdeletion and potentially complicate postnatal treatment.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26113195     DOI: 10.1159/000433430

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  7 in total

1.  Prenatal diagnosis of pulmonary atresia with ventricular septal defect.

Authors:  Shui-Hua Yang; Peng-Hui Luo; Xiao-Xian Tian; Xin-Yan Li; Xue-Qin Li; Zuo-Jian Yang; Sheng-Li Li
Journal:  J Med Ultrason (2001)       Date:  2017-07-27       Impact factor: 1.314

Review 2.  Prenatal Diagnosis of Dextrocardia with Complex Congenital Heart Disease Using Fetal Intelligent Navigation Echocardiography (FINE) and a Literature Review.

Authors:  Lami Yeo; Suchaya Luewan; Dor Markush; Navleen Gill; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2017-06-23       Impact factor: 2.587

3.  Evaluation of right ventricular volume and systolic function in normal fetuses using intelligent spatiotemporal image correlation.

Authors:  Jia-Xing Sun; Ai-Lu Cai; Li-Mei Xie
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

4.  Prenatal Diagnosis of Pulmonary Atresia With Ventricular Septal Defect and an Aberrant Ductus Arteriosus in a Dextrocardia by Two- and Three-Dimensional Echocardiography: A Case Report.

Authors:  Lulu Liang; Yu Wang; Ying Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-01

5.  The prognosis of common arterial trunk from a fetal perspective: A prenatal cohort study and systematic literature review.

Authors:  Amber E L van Nisselrooij; Lotta Herling; Sally-Ann Clur; Ingeborg H Linskens; Eva Pajkrt; Lukas A Rammeloo; Arend D J Ten Harkel; Mark G Hazekamp; Nico A Blom; Monique C Haak
Journal:  Prenat Diagn       Date:  2021-02-26       Impact factor: 3.050

6.  Fetal Intelligent Navigation Echocardiography (FINE) Detects 98% of Congenital Heart Disease.

Authors:  Lami Yeo; Suchaya Luewan; Roberto Romero
Journal:  J Ultrasound Med       Date:  2018-03-30       Impact factor: 2.153

7.  Prenatal diagnosis, associated findings and postnatal outcome of fetuses with truncus arteriosus communis (TAC).

Authors:  J S Abel; C Berg; A Geipel; U Gembruch; U Herberg; J Breuer; K Brockmeier; I Gottschalk
Journal:  Arch Gynecol Obstet       Date:  2021-05-24       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.